Voylenko OA - Search Results

1

Transperitoneal uretercutaneostomy with use of mesosigmoid colon peritoneum in patients with bladder cancer after radical cystectomy.

Stakhovskyi OE, Pikul MV, Semko SL, Vitruk IV, Voylenko OA, Kononenko OA, Grechko BV, Stakhovsky EO. Stakhovskyi OE, et al. Among authors: voylenko oa. Wiad Lek. 2020;73(5):988-993. Wiad Lek. 2020. PMID: 32386382

2

Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion.

Stakhovskyi OE, Semko SL *, Pikul MV, Grechko BO, Voylenko OA, Kononenko OA, Vitruk IV, Stakhovsky EO. Stakhovskyi OE, et al. Among authors: voylenko oa. Exp Oncol. 2020 Sep;42(3):224-227. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-3.15047. Exp Oncol. 2020. PMID: 32996737

3

A case of synchronous bilateral calyx urothelial carcinoma: combined treatment approach.

Semko S, Pikul M, Voylenko O, Stakhovskyi O, Kononenko O, Vitruk Y, Stakhovsky E. Semko S, et al. Exp Oncol. 2019 Mar;41(1):76-79. Exp Oncol. 2019. PMID: 30932402

4

Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localised Clear-Cell Renal Cell Carcinoma.

Voylenko OA, Stakhovsky OE, Vitruk IV, Kononenko OA, Pikul MV, Semko SL, Stakhovsky EO. Voylenko OA, et al. Adv Urol. 2021 Apr 30;2021:6674637. doi: 10.1155/2021/6674637. eCollection 2021. Adv Urol. 2021. PMID: 34012466 Free PMC article.

5

Advantages of organ-sparing treatment approaches in metastatic kidney cancer.

Vitruk I, Voylenko O, Stakhovsky O, Kononenko O, Pikul M, Semko S, Hrechko B, Koshel D, Stakhovsky E. Vitruk I, et al. J Cancer Res Clin Oncol. 2023 Jul;149(7):3131-3137. doi: 10.1007/s00432-022-04216-6. Epub 2022 Jul 23. J Cancer Res Clin Oncol. 2023. PMID: 35870012

6

Evaluation of response to tyrosine kinase inhibitors in renal cell carcinoma patients based on expression of miR-99b, -144, -210, -222, -302а and -377 in tumor tissue.

Vitruk Yu V, Semko SL, Voylenko OA, Pikul MV, Borikun TV, Zadvornyi TV, Yalovenko TM, Stakhovsky EO, Rossylna OV. Vitruk Yu V, et al. Among authors: voylenko oa. Exp Oncol. 2021 Jun;43(2):98-103. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-2.16383. Exp Oncol. 2021. PMID: 34190510

7

Immune Microenvironment of Muscular-Invasive Urothelial Carcinoma: The Link to Tumor Immune Cycle and Prognosis.

Stakhovskyi O, Kobyliak N, Voylenko O, Stakhovskyi E, Ponomarchuk R, Sulaieva O. Stakhovskyi O, et al. Cells. 2022 May 31;11(11):1802. doi: 10.3390/cells11111802. Cells. 2022. PMID: 35681497 Free PMC article.

8

EXPRESSION OF miRNA AS PROGNOSTIC MARKERS OF RENAL CELL CARCINOMA COURSE.

Vitruk Y, Borikun T, Rossylna O, Zadvornyi T, Semko S, Voylenko O, Stakhovsky O, Shipko A, Stakhovsky E. Vitruk Y, et al. Exp Oncol. 2022 Aug;44(2):132-136. doi: 10.32471/exp-oncology.2312-8852.vol-44-no-2.17883. Exp Oncol. 2022. PMID: 35964649

9

[TACTICS OF TREATMENT OF PATIENTS FOR ONCOLOGICAL DISEASES IN IATROGENIC INJURY OF UPPER URINARY WAYS].

Stakhovskyi EO, Vukalovych PS, Voylenko OA, Stakhovskyi OE, Vitruk YV, Kononenko OA. Stakhovskyi EO, et al. Among authors: voylenko oa. Klin Khir. 2015 Oct;(10):52-6. Klin Khir. 2015. PMID: 26946663 Ukrainian.

10

[PECULIARITIES OF METHOD AND RESULTS OF PLASTY, USING INTESTINAL SEGMENT, FOR IATROGENIC INJURY OF URETER].

Stakhovskiy EO, Vukalovych PS, Voylenko OA, Stakhovskiy OE, Vitruk YV, Kononenko OA. Stakhovskiy EO, et al. Among authors: voylenko oa. Klin Khir. 2015 Aug;(8):54-7. Klin Khir. 2015. PMID: 26591867 Ukrainian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters